Reliability of Polish-Version Overactive Bladder Syndrom Scores (OABSS)
NCT ID: NCT03801239
Last Updated: 2019-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
822 participants
OBSERVATIONAL
2017-06-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reliability of KHQ and ICIQ-SF in Assessing Urinary Incontinence Effects in Polish Women
NCT04619238
Health-related QoF Between OAB-wet and OAB-dry Women
NCT03806855
Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women
NCT03106103
Impact of OAB Symptoms on Quality of Life in Croatia
NCT04865328
Sensory Sensitivity and Urinary Symptoms in the Female Population
NCT01978002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with Overactive Bladder (OAB)
Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.
Urodynamic Study
during visit Week 0 patients had urodynamic study
OABSS questionnaire fulfilment
during visit Week 0 and Week 2 patients fulfilled OABSS
UDI-6 questionnaire fulfilment
during visit Week 2 patients fulfilled UDI-6 questionnaire
IIQ-7 questionnaire fulfilment
during visit Week 2 patients fulfilled IIQ-7 questionnaire
patients with Mixed Urinary incontinence (MUI)
Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.
Urodynamic Study
during visit Week 0 patients had urodynamic study
OABSS questionnaire fulfilment
during visit Week 0 and Week 2 patients fulfilled OABSS
UDI-6 questionnaire fulfilment
during visit Week 2 patients fulfilled UDI-6 questionnaire
IIQ-7 questionnaire fulfilment
during visit Week 2 patients fulfilled IIQ-7 questionnaire
patients with Stress Urinary Incontinence (SUI)
Patients completed the Polish version of the OABSS on two separate visits: Week 0 and Week 2 and additionally UDI-6, IIQ-7 during visit- Week 2.
Urodynamic Study
during visit Week 0 patients had urodynamic study
OABSS questionnaire fulfilment
during visit Week 0 and Week 2 patients fulfilled OABSS
UDI-6 questionnaire fulfilment
during visit Week 2 patients fulfilled UDI-6 questionnaire
IIQ-7 questionnaire fulfilment
during visit Week 2 patients fulfilled IIQ-7 questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urodynamic Study
during visit Week 0 patients had urodynamic study
OABSS questionnaire fulfilment
during visit Week 0 and Week 2 patients fulfilled OABSS
UDI-6 questionnaire fulfilment
during visit Week 2 patients fulfilled UDI-6 questionnaire
IIQ-7 questionnaire fulfilment
during visit Week 2 patients fulfilled IIQ-7 questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* female aged 18-75 years old
Exclusion Criteria
* uncontrolled diabetes
* inability to understand informed consent
18 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Lublin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrzej Wróbel
PhD, MD associated professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Lublin
Lublin, Lublin Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
01/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.